CURAPATH

Curapath, based in Valencia, Spain, is a science-driven CDMO specializing in the design, development, and GMP manufacturing of advanced drug delivery systems, with particular expertise in synthetic polyaminoacids and polypeptoids and GMP-certified excipient and drug product fill-and-finish across flexible volumes from preclinical to commercial scale. The company holds proprietary technology for polymeric nanoparticle delivery vehicles for nucleic acids and peptides, shielding and ionizable lipids for lipid nanoparticles, and targeted nanoparticle conjugation, and offers intermediates, finished dosage forms, excipients, packaging and drug delivery products, and outsourcing services under OEM, ODM, and its own brand. With roughly 90% of sales exported to North America, Western Europe, and Australasia, Curapath is recognized for its brand, international certifications, experienced R&D team, rich product line, and high-quality, buyer-responsive service.